pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4699 |
Genomic Coordinates | chr12: 81158388 - 81158461 |
Description | Homo sapiens miR-4699 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4699-3p | |||||||||||||||
Sequence | 46| AAUUUACUCUGCAAUCUUCUCC |67 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
|||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SLC38A2 | ||||||||||||||||||||
Synonyms | ATA2, PRO1068, SAT2, SNAT2 | ||||||||||||||||||||
Description | solute carrier family 38 member 2 | ||||||||||||||||||||
Transcript | NM_018976 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SLC38A2 | |||||||||||||||||||||
3'UTR of SLC38A2 (miRNA target sites are highlighted) |
>SLC38A2|NM_018976|3'UTR 1 TTGGCACCACTCAAACTCAAACTCAGTCCATCTGATGCCAGTGTTGAGTAAACTCAACTACTATGAAATTTCACCTAATG 81 TTTTCAGTTTCACTTCCTTTTGAAGTGCAGATTCCTCGCTGGTTCTTCTGAGTGCAGAATAAGTGAACTTTTTTGTTTTG 161 TTTTGTTTTTTTAAGAAACTTATCTGTATGTTAGAAATGGATATGAACAACAAAACCACGAGTCTCGGGTTAAGGGAAGT 241 GACAATTTTATTCCATTCCAGAGAATGGACAAACTCTTAACTTTTATCAAGCCACATGCTTGGCTGTGTCATTGTTTAAC 321 TTGGATATTTTATGATTTTACTTGAATGTGCCTAATGGAACCATTTGATGTGAGAAACAATTCTTTTTAATTTACAGCAA 401 AATATTGAATAACCATTGACAAAAACACTATTATTTTTTGTACCAAAAATACTTAAAGACCTCAGAAGCACTCTTTTACT 481 TTTAAGAAATTGCTTTTTTGAACTTTATTCAGAAGCAGTTATCAATAAATTCCATAAAATAATGTCATTGGTATTTAAAA 561 ATGAATATTAATATAATGAAATGGTTTGCCTTTTTGTAGGCATAATAAGCCAAATACTTTTTTACCCAAAATAATTTTTA 641 GAGAAAATGATGTAATGAAAAATTGTACCATGAATTAGGAGCATAGTTTTTTCCATTTAAACGTCACCATTACTTAAAAG 721 ATGATTGATTATTGCTATACCAAATCAGATGAACTCTGTTCATCACTTTTCTTCTCTGTCCCCAAACAATTTGGTTCATT 801 CAGACTGAAATGTTTGTGTCTTCAACTTATTAGAATGGAAGATAATGCAGATATTTCTGTGGGAAATAAAATAACTAATT 881 TTGAGGTACCAAATAGTGCAATTGGGTAAAACAGGGTTTATTCAGTTGCATCTGTCTCCAGTGTTGTATTGACAGCTCTG 961 GGTCTTTTTTTGGGCCAGCCCTTTTTTGACATTGCTTCCAGCAGTGGAAAATGGGCATTTGATGGCAATAGGCCAAAATT 1041 ATTGTGTCCAGAGAGTACACTTTTTCAAAATGCTCACCTACTGGAAGTGTGAATTACTTGACAATGTATGGCTTAGTTGT 1121 GTTCATGTTTTGTCTACAGTAGAGGTCTAATCCACAGGTTACACCTATGTTTGATATGATATAAGTTCTCTTTGCGTAGG 1201 CCACTGGGTTTCTCATGCAGTAAGCTTTATAAAAACTCATTTGCACTGGACTGTCATCTCATTCTTGTACAACGTAGAAT 1281 TACTTGTTTACATCCAACAAATGGTTAGCTAGGGAAAACAGTGCAAACTGAGTGTTAGTAGTCATTTTGGTCCAACTGCA 1361 TGTCAACCCTTCCATTTCAATCCCAGTTAGAAATGAAAATAATTACTTTGAAACTTGGCTTTAAGAGCACATTTATCGTA 1441 CGTCACAGTGTATGGTGAATATATTATTAAATAATGTGGTACTTCGCTCATCAGGCATAATGTCTAAAATCTAATATACA 1521 TAATTCCATTAAGTGGTTGAAGGAAGCAAATAATGGAATTGTCAATTGGTCATCTGGCTGTAAGGTTTGCCCTTGAACTA 1601 AAAATGTTGTTTGGGGCAAGGGCCAGAAATGTGGAGACATGGTTTTTGTTACGCATTCTTGTATTATATGTGACTAAATT 1681 TACAAACAAGATACATGTGTAATTAAAGACCCTTATGGAACTGGAAGACGTCTTGTAGTGCTACATTGGGTGAAACCGTT 1761 GGTCCATTTTTGTCTGTTTCTATGAAGATAAAATAATTGGGGGCCATCTAGAAATAGAAAGGCAGTGGGAAGACAGATTC 1841 TACGGCACTGCTTTCATTTAATTGGGCTTTAGGCACTCCATTCGAATGCAGAACCTCACCTCTAGTTGAGACCAAGAATT 1921 GGCAAATTTGCATGAGCTCCTGGAAAGAGTTGCTGACTTTGTATCTAAGACCTGCCAGGGAATACCAAGAGTTGTTTCTA 2001 CAGACTTTTTTTTTTTTTTTTGTATGGGAGAAGATACTGTGGCAACCAGGAAGGAATGGAAAAAAAATTCTTTTCTCTAC 2081 AGCAAATTAATGTGAGGAAGCTCCTCCAATCCTCTGGCTATTTAAGGTTCAAAATCAAGTGCCTAGGGAAAATTCCAATG 2161 GATGATTTTCTGGGAGCTATCTTGTCTACCTTGAGGTTCCTGAACAATGAATTCCCATTAATGAGCAGTCTTCAGTATTA 2241 AAACCACTGTCTTGTCACCTCATTTTGCATTACTGTCTTCCGTGGATGTTTCAGTTACAACTGTAATGTTATTTATAGAA 2321 CAACATTAATCCATTAAAGCTAACCTATTTTTCAATATTTATGATAATCTATGTACATATATTGTCTGTCCATATGTATT 2401 TGTAAATAGGTTGTATATAATGTCAGGTTTGGGTCTTGGGTTCAAGTGTATATATTCCTGTAAGTTTCTTAACTGCATTT 2481 TGATGAATTCACATTATGTAACTATAAGAATTGTCCCAAAAGTACCTGTACAGAAAATTGAATATTGAAAAATTGACAAA 2561 TTGTGTACAAACACTAAAAAAAACTTGTTTAAATTGTATTTGCAATAAACAACATCAAATTTTTTCATGAAATCTTGGTA 2641 CAAATTCAGATCTCTTATTTAAAATTTAAATAAGGAATACATTTTCAAAATGCAGTAATCAAAATGTGATCTAGTGTAAT 2721 GAAATAAAATGTGATCTAGTGTAATGGAAGACCTTTGAGAACCTGGGTGTATTAACTTTGTGTATATAGTGTAAATATCC 2801 CCACTGTACTGTTAGAGGCCAACAATTCTAGTATGGCTTGTTGGCAAAGAGTGCTACACCGTTTCAATGAAACAATGTAT 2881 GTTTGTTTTAACTGAACTAAAATAAATACATGCTTAATCCTGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 2961 AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 54407.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM4903825 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID14_NS |
Location of target site | NM_018976 | 3UTR | AAAAUGUGAUCUAGUGUAAUGGAAGACCUUUGAGAACCUGGGUGUAUUAACUUUGUGUAUAUAGUGUAAAUAUCCCCACUGUACUGUUAGAGGCCAACAAUUCUAGUAUGGCUUGUUGGCAAAGAGUGCUACACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903826 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID21_NS |
Location of target site | NM_018976 | 3UTR | UUUGUAAAUAGGUUGUAUAUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903827 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID14_9124 |
Location of target site | NM_018976 | 3UTR | AAAUAGGUUGUAUAUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903828 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID21_9124 |
Location of target site | NM_018976 | 3UTR | AUGUAUUUGUAAAUAGGUUGUAUAUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_018976 | 3UTR | AAACAACAUCAAAUUUUUUCAUGAAAUCUUGGUACAAAUUCAGAUCUCUUAUUUAAAAUUUAAAUAAGGAAUACAUUUUCAAAAUGCAGUAAUCAAAAUGUGAUCUAGUGUAAUGAAAUAAAAUGUGAUCUAGUGUAAUGGAAGACCUUUGAGAACCUGGGUGUAUUAACUUUGUGUAUAUAGUGUAAAUAUCCCCACUGUACUGUUAGAGGCCAACAAUUCUAGUAUGGCUUGUUGGCAAAGAGUGCUACACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_018976 | 3UTR | UCUUGGUACAAAUUCAGAUCUCUUAUUUAAAAUUUAAAUAAGGAAUACAUUUUCAAAAUGCAGUAAUCAAAAUGUGAUCUAGUGUAAUGAAAUAAAAUGUGAUCUAGUGUAAUGGAAGACCUUUGAGAACCUGGGUGUAUUAACUUUGUGUAUAUAGUGUAAAUAUCCCCACUGUACUGUUAGAGGCCAACAAUUCUAGUAUGGCUUGUUGGCAAAGAGUGCUACACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_018976 | 3UTR | UUGGUACAAAUUCAGAUCUCUUAUUUAAAAUUUAAAUAAGGAAUACAUUUUCAAAAUGCAGUAAUCAAAAUGUGAUCUAGUGUAAUGAAAUAAAAUGUGAUCUAGUGUAAUGGAAGACCUUUGAGAACCUGGGUGUAUUAACUUUGUGUAUAUAGUGUAAAUAUCCCCACUGUACUGUUAGAGGCCAACAAUUCUAGUAUGGCUUGUUGGCAAAGAGUGCUACACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_018976 | 3UTR | UGUAAAUAUCCCCACUGUACUGUUAGAGGCCAACAAUUCUAGUAUGGCUUGUUGGCAAAGAGUGCUACACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_018976 | 3UTR | AUUUUCAAAAUGCAGUAAUCAAAAUGUGAUCUAGUGUAAUGAAAUAAAAUGUGAUCUAGUGUAAUGGAAGACCUUUGAGAACCUGGGUGUAUUAACUUUGUGUAUAUAGUGUAAAUAUCCCCACUGUACUGUUAGAGGCCAACAAUUCUAGUAUGGCUUGUUGGCAAAGAGUGCUACACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 10 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_018976 | 3UTR | UUUAAAUAAGGAAUACAUUUUCAAAAUGCAGUAAUCAAAAUGUGAUCUAGUGUAAUGAAAUAAAAUGUGAUCUAGUGUAAUGGAAGACCUUUGAGAACCUGGGUGUAUUAACUUUGUGUAUAUAGUGUAAAUAUCCCCACUGUACUGUUAGAGGCCAACAAUUCUAGUAUGGCUUGUUGGCAAAGAGUGCUACACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 11 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000256689.5 | 3UTR | UGUAUAUAGUGUAAAUAUCCCCACUGUACUGUUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 12 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000256689.5 | 3UTR | UGUAUAUAGUGUAAAUAUCCCCACUGUACUGUUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
88 hsa-miR-4699-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT056239 | RAB18 | RAB18, member RAS oncogene family | 2 | 2 | ||||||||
MIRT080536 | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 2 | 2 | ||||||||
MIRT095600 | NR3C1 | nuclear receptor subfamily 3 group C member 1 | 2 | 2 | ||||||||
MIRT128911 | KMT2A | lysine methyltransferase 2A | 2 | 2 | ||||||||
MIRT161904 | FXR1 | FMR1 autosomal homolog 1 | 2 | 4 | ||||||||
MIRT177614 | UBE2D1 | ubiquitin conjugating enzyme E2 D1 | 2 | 4 | ||||||||
MIRT231364 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | 2 | 6 | ||||||||
MIRT285164 | SERBP1 | SERPINE1 mRNA binding protein 1 | 2 | 2 | ||||||||
MIRT307337 | SEC22C | SEC22 homolog C, vesicle trafficking protein | 2 | 2 | ||||||||
MIRT317083 | DEK | DEK proto-oncogene | 2 | 2 | ||||||||
MIRT347692 | LSM14A | LSM14A, mRNA processing body assembly factor | 2 | 2 | ||||||||
MIRT358438 | STC2 | stanniocalcin 2 | 2 | 2 | ||||||||
MIRT362592 | PURB | purine rich element binding protein B | 2 | 4 | ||||||||
MIRT441441 | HAVCR1 | hepatitis A virus cellular receptor 1 | 2 | 2 | ||||||||
MIRT445264 | LOH12CR2 | loss of heterozygosity, 12, chromosomal region 2 (non-protein coding) | 2 | 4 | ||||||||
MIRT447097 | SNRPD1 | small nuclear ribonucleoprotein D1 polypeptide | 2 | 2 | ||||||||
MIRT449013 | ANKRD17 | ankyrin repeat domain 17 | 2 | 2 | ||||||||
MIRT450358 | SETD9 | SET domain containing 9 | 2 | 2 | ||||||||
MIRT454976 | MYC | MYC proto-oncogene, bHLH transcription factor | 2 | 2 | ||||||||
MIRT461922 | NECAB3 | N-terminal EF-hand calcium binding protein 3 | 2 | 2 | ||||||||
MIRT465191 | TRPS1 | transcriptional repressor GATA binding 1 | 2 | 2 | ||||||||
MIRT467685 | SLC38A2 | solute carrier family 38 member 2 | 2 | 4 | ||||||||
MIRT468003 | SKI | SKI proto-oncogene | 2 | 2 | ||||||||
MIRT473127 | MLLT10 | MLLT10, histone lysine methyltransferase DOT1L cofactor | 2 | 2 | ||||||||
MIRT476370 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 2 | ||||||||
MIRT477067 | FAM208B | family with sequence similarity 208 member B | 2 | 4 | ||||||||
MIRT479950 | CBX4 | chromobox 4 | 2 | 4 | ||||||||
MIRT481092 | B3GNT2 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | 2 | 2 | ||||||||
MIRT481932 | ANKRD11 | ankyrin repeat domain 11 | 2 | 12 | ||||||||
MIRT482239 | AHCY | adenosylhomocysteinase | 2 | 2 | ||||||||
MIRT485804 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 2 | ||||||||
MIRT492026 | TWF1 | twinfilin actin binding protein 1 | 2 | 2 | ||||||||
MIRT494389 | CALM3 | calmodulin 3 | 2 | 2 | ||||||||
MIRT504115 | GPR158 | G protein-coupled receptor 158 | 2 | 2 | ||||||||
MIRT506346 | NUP54 | nucleoporin 54 | 2 | 4 | ||||||||
MIRT510081 | PPWD1 | peptidylprolyl isomerase domain and WD repeat containing 1 | 2 | 4 | ||||||||
MIRT521019 | SLC8A1 | solute carrier family 8 member A1 | 2 | 2 | ||||||||
MIRT524709 | BTBD3 | BTB domain containing 3 | 2 | 2 | ||||||||
MIRT524989 | AGO2 | argonaute 2, RISC catalytic component | 2 | 6 | ||||||||
MIRT525003 | ACVR1B | activin A receptor type 1B | 2 | 2 | ||||||||
MIRT528064 | OLAH | oleoyl-ACP hydrolase | 2 | 2 | ||||||||
MIRT528865 | C1orf147 | chromosome 1 open reading frame 147 | 2 | 2 | ||||||||
MIRT532182 | DOCK7 | dedicator of cytokinesis 7 | 2 | 2 | ||||||||
MIRT533592 | TOB1 | transducer of ERBB2, 1 | 2 | 6 | ||||||||
MIRT538835 | C16orf70 | chromosome 16 open reading frame 70 | 2 | 2 | ||||||||
MIRT539488 | ACVR1C | activin A receptor type 1C | 2 | 2 | ||||||||
MIRT539542 | ABCD2 | ATP binding cassette subfamily D member 2 | 2 | 2 | ||||||||
MIRT542123 | VENTX | VENT homeobox | 2 | 2 | ||||||||
MIRT542993 | ELOVL5 | ELOVL fatty acid elongase 5 | 2 | 2 | ||||||||
MIRT543067 | ATXN7L3B | ataxin 7 like 3B | 2 | 2 | ||||||||
MIRT543370 | CYB5B | cytochrome b5 type B | 2 | 2 | ||||||||
MIRT545080 | TSEN34 | tRNA splicing endonuclease subunit 34 | 2 | 2 | ||||||||
MIRT545258 | TRIM36 | tripartite motif containing 36 | 2 | 4 | ||||||||
MIRT549144 | BRIX1 | BRX1, biogenesis of ribosomes | 2 | 2 | ||||||||
MIRT549403 | AKAP1 | A-kinase anchoring protein 1 | 2 | 2 | ||||||||
MIRT552143 | MRPL34 | mitochondrial ribosomal protein L34 | 2 | 2 | ||||||||
MIRT554781 | RHEBP1 | RHEB pseudogene 1 | 2 | 4 | ||||||||
MIRT555991 | NFYB | nuclear transcription factor Y subunit beta | 2 | 2 | ||||||||
MIRT556425 | LONRF3 | LON peptidase N-terminal domain and ring finger 3 | 2 | 2 | ||||||||
MIRT558325 | DNAJC28 | DnaJ heat shock protein family (Hsp40) member C28 | 2 | 4 | ||||||||
MIRT561357 | YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta | 2 | 2 | ||||||||
MIRT562240 | HMGB1 | high mobility group box 1 | 2 | 2 | ||||||||
MIRT562269 | GOLT1B | golgi transport 1B | 2 | 2 | ||||||||
MIRT564020 | FAM103A1 | family with sequence similarity 103 member A1 | 2 | 2 | ||||||||
MIRT564832 | ZBTB16 | zinc finger and BTB domain containing 16 | 2 | 2 | ||||||||
MIRT565350 | TMED2 | transmembrane p24 trafficking protein 2 | 2 | 2 | ||||||||
MIRT565678 | SET | SET nuclear proto-oncogene | 2 | 2 | ||||||||
MIRT576547 | Txlna | taxilin alpha | 2 | 2 | ||||||||
MIRT609358 | ZNF664 | zinc finger protein 664 | 2 | 2 | ||||||||
MIRT610646 | CTGF | connective tissue growth factor | 2 | 2 | ||||||||
MIRT624681 | ARAP2 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 | 2 | 2 | ||||||||
MIRT637118 | AGTPBP1 | ATP/GTP binding protein 1 | 2 | 2 | ||||||||
MIRT639955 | PRRC2B | proline rich coiled-coil 2B | 2 | 2 | ||||||||
MIRT644051 | WWC2 | WW and C2 domain containing 2 | 2 | 2 | ||||||||
MIRT650463 | SLC35B1 | solute carrier family 35 member B1 | 2 | 2 | ||||||||
MIRT651094 | ZNF516 | zinc finger protein 516 | 2 | 2 | ||||||||
MIRT655268 | PER2 | period circadian clock 2 | 2 | 2 | ||||||||
MIRT657450 | HEYL | hes related family bHLH transcription factor with YRPW motif-like | 2 | 2 | ||||||||
MIRT692248 | POLR3F | RNA polymerase III subunit F | 2 | 2 | ||||||||
MIRT695239 | PBK | PDZ binding kinase | 2 | 2 | ||||||||
MIRT696024 | NDUFS3 | NADH:ubiquinone oxidoreductase core subunit S3 | 2 | 2 | ||||||||
MIRT698486 | TIAL1 | TIA1 cytotoxic granule associated RNA binding protein like 1 | 2 | 2 | ||||||||
MIRT700581 | PRSS22 | protease, serine 22 | 2 | 2 | ||||||||
MIRT704540 | CNEP1R1 | CTD nuclear envelope phosphatase 1 regulatory subunit 1 | 2 | 2 | ||||||||
MIRT704723 | CEP135 | centrosomal protein 135 | 2 | 2 | ||||||||
MIRT705194 | BTG1 | BTG anti-proliferation factor 1 | 2 | 2 | ||||||||
MIRT710286 | CSNK1G3 | casein kinase 1 gamma 3 | 2 | 2 | ||||||||
MIRT719623 | TUBGCP3 | tubulin gamma complex associated protein 3 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|